Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agile Therapeutics Inc
(NQ:
AGRX
)
0.2300
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
60
Open
0.2300
Bid (Size)
0.2200 (2)
Ask (Size)
0.2500 (1)
Prev. Close
0.2300
Today's Range
0.2300 - 0.2300
52wk Range
0.1750 - 11.40
Shares Outstanding
46,538,250
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 23, 2023
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
Via
Benzinga
Agile Therapeutics's Return On Capital Employed Insights
March 23, 2023
Via
Benzinga
Performance
YTD
+6.14%
+6.14%
1 Month
-4.64%
-4.64%
3 Month
+16.75%
+16.75%
6 Month
-18.96%
-18.96%
1 Year
-97.79%
-97.79%
More News
Read More
Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
March 23, 2023
Via
Benzinga
Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women
January 20, 2023
Via
TheNewswire.com
HC Wainwright & Co. Maintains Buy Rating for Agile Therapeutics: Here's What You Need To Know
December 30, 2022
Via
Benzinga
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
March 22, 2023
From
Agile Therapeutics, Inc.
Via
Globe NewsWire
Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023
March 21, 2023
From
Agile Therapeutics, Inc.
Via
Globe NewsWire
Agile Therapeutics Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement
February 27, 2023
From
Agile Therapeutics, Inc.
Via
Globe NewsWire
Agile Therapeutics Earnings Perspective: Return On Capital Employed
November 29, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 02, 2023
Via
InvestorPlace
Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation
February 01, 2023
From
Agile Therapeutics, Inc.
Via
Globe NewsWire
Agile Therapeutics Announces Distribution of Series C Preferred Stock to its Holders of Common Stock
January 26, 2023
From
Agile Therapeutics, Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
January 20, 2023
Via
Benzinga
Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women
January 20, 2023
Via
News Direct
Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women
January 19, 2023
Via
Benzinga
Agile Therapeutics Provides Updates on 2022 Twirla Performance and 2023 Commercial Plan
January 09, 2023
From
Agile Therapeutics, Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 03, 2023
Via
Benzinga
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
December 30, 2022
Via
Benzinga
This Biotech Company is Pursuing Positive Cash Flow In 2023
December 21, 2022
Via
TheNewswire.com
This Biotech Company is Pursuing Positive Cash Flow In 2023
December 21, 2022
Via
News Direct
This Biotech Company is Pursuing Positive Cash Flow In 2023
December 20, 2022
Via
Benzinga
Agile Therapeutics To Present At The Upcoming RHK Capital Disruptive Growth Conference
December 01, 2022
From
Agile Therapeutics, Inc.
Via
Globe NewsWire
Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
November 15, 2022
Via
News Direct
Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
November 15, 2022
Via
TheNewswire.com
Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
November 14, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
